Cantor Fitzgerald, L. P.

Source: SEC Form 13F · as of Mar 2026

Cantor Fitzgerald, L. P. holds 29 biotech & pharma companies tracked by BioSniper, totaling $239.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$239.3M

CompanySharesValue
UNHUnitedHealth Group Incorporated Common Stock (DE)615,550$166.6M
NVONovo Nordisk A/S461,574$17.0M
LLYELI LILLY & Co18,137$16.7M
IMCRImmunocore Holdings plc300,711$9.1M
RIOTRiot Platforms, Inc.444,135$5.5M
PMPhilip Morris International Inc21,647$3.6M
RNAAtrium Therapeutics Inc.235,637$3.2M
CABACabaletta Bio, Inc.765,000$2.1M
VSTMVerastem, Inc.363,132$1.9M
OSCROscar Health Inc.161,328$1.9M
INSMINSMED Inc11,000$1.8M
ACOGAlpha Cognition Inc.188,631$1.0M
SLNOSOLENO THERAPEUTICS INC30,000$1.0M
RCUSArcus Biosciences, Inc.45,000$972K
PTHSPelthos Therapeutics Inc.41,423$870K
ANTXAN2 Therapeutics, Inc.200,000$684K
TLPHTALPHERA, INC.887,481$663K
TRDAEntrada Therapeutics, Inc.47,000$593K
EQEquillium, Inc.262,643$525K
MRNAModerna, Inc.10,009$508K
BNTCBenitec Biopharma Inc.46,659$497K
UNCYUnicycive Therapeutics, Inc.75,000$494K
RAREUltragenyx Pharmaceutical Inc.19,924$417K
OKUROnKure Therapeutics, Inc.99,900$414K
CRBPCorbus Pharmaceuticals Holdings, Inc.40,098$377K
ADCTADC Therapeutics SA100,000$375K
ANLAdlai Nortye Ltd.40,310$279K
AARDAardvark Therapeutics, Inc.66,682$251K
CLYMClimb Bio, Inc.30,000$206K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Cantor Fitzgerald, L. P. — Biotech 13F Holdings & Portfolio | BioSniper